BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31586772)

  • 1. The effect of melatonin on depressive symptoms and anxiety in patients after acute coronary syndrome: The MEDACIS randomized clinical trial.
    Madsen MT; Zahid JA; Hansen CH; Grummedal O; Hansen JR; Isbrand A; Andersen UO; Andersen LJ; Taskiran M; Simonsen E; Gögenur I
    J Psychiatr Res; 2019 Dec; 119():84-94. PubMed ID: 31586772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of MElatonin on Depressive symptoms, Anxiety, CIrcadian and Sleep disturbances in patients after acute coronary syndrome (MEDACIS): study protocol for a randomized controlled trial.
    Madsen MT; Isbrand A; Andersen UO; Andersen LJ; Taskiran M; Simonsen E; Gögenur I
    Trials; 2017 Feb; 18(1):81. PubMed ID: 28228148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of melatonin on depressive symptoms and anxiety in patients undergoing breast cancer surgery: a randomized, double-blind, placebo-controlled trial.
    Hansen MV; Andersen LT; Madsen MT; Hageman I; Rasmussen LS; Bokmand S; Rosenberg J; Gögenur I
    Breast Cancer Res Treat; 2014 Jun; 145(3):683-95. PubMed ID: 24756186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Melatonin Upon Postacute Withdrawal Among Males in a Residential Treatment Program (M-PAWS): A Randomized, Double-blind, Placebo-controlled Trial.
    Bondi CD; Kamal KM; Johnson DA; Witt-Enderby PA; Giannetti VJ
    J Addict Med; 2018; 12(3):201-206. PubMed ID: 29351138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial.
    Davidson KW; Rieckmann N; Clemow L; Schwartz JE; Shimbo D; Medina V; Albanese G; Kronish I; Hegel M; Burg MM
    Arch Intern Med; 2010 Apr; 170(7):600-8. PubMed ID: 20386003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation of the glucocorticoid receptor gene associated with depression in patients with acute coronary syndrome.
    Kang HJ; Bae KY; Kim SW; Shin IS; Kim HR; Shin MG; Hong YJ; Ahn Y; Jeong MH; Yoon JS; Kim JM
    Psychoneuroendocrinology; 2019 Mar; 101():42-49. PubMed ID: 30408722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic antidepressant treatment following acute coronary syndrome: A systematic review of randomized controlled trials.
    Christiansen OG; Madsen MT; Simonsen E; Gögenur I
    J Psychiatr Res; 2017 Nov; 94():186-193. PubMed ID: 28746904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of escitalopram in prevention of depression in patients with acute coronary syndrome (DECARD).
    Hansen BH; Hanash JA; Rasmussen A; Hansen JF; Andersen NL; Nielsen OW; Birket-Smith M
    J Psychosom Res; 2012 Jan; 72(1):11-6. PubMed ID: 22200516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronobiology, cognitive function and depressive symptoms in surgical patients.
    Hansen MV
    Dan Med J; 2014 Sep; 61(9):B4914. PubMed ID: 25186550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of adjuvant omega-3-polyunsaturated fatty acids on depression, sleep, and emotion regulation among outpatients with major depressive disorders - Results from a double-blind, randomized and placebo-controlled clinical trial.
    Jahangard L; Sadeghi A; Ahmadpanah M; Holsboer-Trachsler E; Sadeghi Bahmani D; Haghighi M; Brand S
    J Psychiatr Res; 2018 Dec; 107():48-56. PubMed ID: 30317101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale, design, and baseline data for a multicenter randomized clinical trial comparing depression screening strategies after acute coronary syndrome: The comparison of depression identification after acute Coronary Syndromes-Quality of Life and Cost Outcomes (CODIACS-QOL) trial.
    Moise N; Davidson KW; Cheung YKK; Clarke GN; Dolor RJ; Duer-Hefele J; Ladapo JA; Margolis KL; St Onge T; Parsons F; Retuerto J; Schmit KM; Thanataveerat A; Kronish IM
    Contemp Clin Trials; 2019 Sep; 84():105826. PubMed ID: 31419605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BDNF methylation and depressive disorder in acute coronary syndrome: The K-DEPACS and EsDEPACS studies.
    Kim JM; Stewart R; Kang HJ; Bae KY; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Yoon JS
    Psychoneuroendocrinology; 2015 Dec; 62():159-65. PubMed ID: 26313133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of melatonin on endothelial dysfunction in patients after acute coronary syndrome: The MEFACS randomized clinical trial.
    Zahid JA; Isbrand A; Kleif J; Schou-Pedersen AV; Lykkesfeldt J; Madsen MT; Gögenur I
    J Pineal Res; 2019 Oct; 67(3):e12600. PubMed ID: 31355944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant therapy with antidepressants for the management of inflammatory bowel disease.
    Mikocka-Walus A; Prady SL; Pollok J; Esterman AJ; Gordon AL; Knowles S; Andrews JM
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012680. PubMed ID: 30977111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial FLOwering plants in Reducing Anxiety and depressive symptoms following Acute Coronary Syndromes (A-FLORA-ACS): a randomised controlled trial.
    Koh Y; Rashid H; Khaw S; Nasis A
    Heart Vessels; 2019 Jun; 34(6):888-897. PubMed ID: 30539231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Social support deficit and depression treatment outcomes in patients with acute coronary syndrome: Findings from the EsDEPACS study.
    Kim JW; Kang HJ; Bae KY; Kim SW; Shin IS; Yoon JS; Hong YJ; Ahn Y; Jeong MH; Kim JM
    Int J Psychiatry Med; 2019 Jan; 54(1):39-52. PubMed ID: 30079814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a nurse-coordinated prevention programme on health-related quality of life and depression in patients with an acute coronary syndrome: results from the RESPONSE randomised controlled trial.
    Jørstad HT; Minneboo M; Helmes HJ; Fagel ND; Scholte Op Reimer WJ; Tijssen JG; Peters RJ
    BMC Cardiovasc Disord; 2016 Jul; 16(1):144. PubMed ID: 27391321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risperidone for treatment-refractory major depressive disorder: a randomized trial.
    Mahmoud RA; Pandina GJ; Turkoz I; Kosik-Gonzalez C; Canuso CM; Kujawa MJ; Gharabawi-Garibaldi GM
    Ann Intern Med; 2007 Nov; 147(9):593-602. PubMed ID: 17975181
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.